| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Additional findings at preoperative MRI: a simple golden rule for a complex problem?
|
Sardanelli, Francesco
|
|
2010
|
124 |
3 |
p. 717-721
|
artikel
|
| 2 |
A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer
|
Liu, Ying
|
|
2010
|
124 |
3 |
p. 835-844
|
artikel
|
| 3 |
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
|
Castellano, Isabella
|
|
2010
|
124 |
3 |
p. 607-617
|
artikel
|
| 4 |
A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results
|
Elshof, Lotte E.
|
|
2010
|
124 |
3 |
p. 707-715
|
artikel
|
| 5 |
Association between androgen receptor gene CAG repeat polymorphism and breast cancer risk: a meta-analysis
|
Hao, YouJin
|
|
2010
|
124 |
3 |
p. 815-820
|
artikel
|
| 6 |
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance
|
Zhao, Xinmin
|
|
2010
|
124 |
3 |
p. 733-743
|
artikel
|
| 7 |
BRCA1/2 test results impact risk management attitudes, intentions, and uptake
|
O’Neill, Suzanne C.
|
|
2010
|
124 |
3 |
p. 755-764
|
artikel
|
| 8 |
Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients
|
Bastiaannet, E.
|
|
2010
|
124 |
3 |
p. 801-807
|
artikel
|
| 9 |
Breast-conserving therapy after previous irradiation for lymphoma
|
Nguyen, Sonia K. A.
|
|
2009
|
124 |
3 |
p. 845-849
|
artikel
|
| 10 |
Clinical significance of a serum CA 15-3 surge and the usefulness of CA 15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer
|
Wu, Shih-Chung
|
|
2010
|
124 |
3 |
p. 879-882
|
artikel
|
| 11 |
Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study
|
Dedes, Konstantin J.
|
|
2010
|
124 |
3 |
p. 653-666
|
artikel
|
| 12 |
Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer
|
Buist, Diana S. M.
|
|
2010
|
124 |
3 |
p. 863-873
|
artikel
|
| 13 |
Endothelial nitric oxide synthase (eNOS) 894 G>T polymorphism is associated with breast cancer risk: a meta-analysis
|
Hao, Youjin
|
|
2010
|
124 |
3 |
p. 809-813
|
artikel
|
| 14 |
Evaluation of the histological size of the sentinel lymph node metastases using RT–PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancer
|
Veys, I.
|
|
2009
|
124 |
3 |
p. 599-605
|
artikel
|
| 15 |
Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma
|
Liu, Fangfang
|
|
2010
|
124 |
3 |
p. 677-688
|
artikel
|
| 16 |
Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: convergence and divergence of the two recent meta-analyses
|
Economopoulos, Konstantinos P.
|
|
2010
|
124 |
3 |
p. 883-887
|
artikel
|
| 17 |
Haplotype analysis of XRCC1 (at codons 194 and 399) and susceptibility to breast cancer, a meta-analysis of the literatures
|
Saadat, Mostafa
|
|
2010
|
124 |
3 |
p. 785-791
|
artikel
|
| 18 |
HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies
|
Lu, Su
|
|
2010
|
124 |
3 |
p. 771-778
|
artikel
|
| 19 |
Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer
|
Wasielewski, Marijke
|
|
2010
|
124 |
3 |
p. 635-641
|
artikel
|
| 20 |
Maternal and paternal lineage double heterozygosity alteration in familial breast cancer: a first case report
|
Pilato, Brunella
|
|
2010
|
124 |
3 |
p. 875-878
|
artikel
|
| 21 |
More radiotherapy for radiation-induced second malignancies?
|
Formenti, Silvia
|
|
2009
|
124 |
3 |
p. 851-852
|
artikel
|
| 22 |
MTRR A66G polymorphism and breast cancer risk: a meta-analysis
|
Hu, Jia
|
|
2010
|
124 |
3 |
p. 779-784
|
artikel
|
| 23 |
No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer
|
Huang, Katie T.
|
|
2010
|
124 |
3 |
p. 853-856
|
artikel
|
| 24 |
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features
|
Montagna, Emilia
|
|
2010
|
124 |
3 |
p. 689-699
|
artikel
|
| 25 |
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
|
Kolk, Dorina M. van der
|
|
2010
|
124 |
3 |
p. 643-651
|
artikel
|
| 26 |
Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case–control study
|
Iwasaki, Motoki
|
|
2010
|
124 |
3 |
p. 827-834
|
artikel
|
| 27 |
Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival
|
Adams, Sylvia
|
|
2010
|
124 |
3 |
p. 723-732
|
artikel
|
| 28 |
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues
|
Launay-Vacher, Vincent
|
|
2008
|
124 |
3 |
p. 745-753
|
artikel
|
| 29 |
Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design
|
Alvarez, Ricardo H.
|
|
2010
|
124 |
3 |
p. 701-705
|
artikel
|
| 30 |
RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects
|
Wang, Zhanwei
|
|
2010
|
124 |
3 |
p. 765-769
|
artikel
|
| 31 |
Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network
|
Cox, Brian
|
|
2010
|
124 |
3 |
p. 793-800
|
artikel
|
| 32 |
Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer
|
Zheng, Yonglan
|
|
2010
|
124 |
3 |
p. 857-861
|
artikel
|
| 33 |
Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells
|
Mern, Demissew S.
|
|
2010
|
124 |
3 |
p. 623-633
|
artikel
|
| 34 |
The androgen receptor in breast cancer: learning from the past
|
Higgins, Michaela J.
|
|
2010
|
124 |
3 |
p. 619-621
|
artikel
|
| 35 |
The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)
|
Fortunati, N.
|
|
2010
|
124 |
3 |
p. 667-675
|
artikel
|
| 36 |
Three polymorphisms in interleukin-1β gene and risk for breast cancer: a meta-analysis
|
Liu, Xiaoan
|
|
2010
|
124 |
3 |
p. 821-825
|
artikel
|
Tijdschrift beschrijving